BNGO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Bionano Genomics Inc (BNGO) is not a strong buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The lack of positive trading signals, weak financial performance, and absence of significant catalysts make it prudent to hold off on investing in this stock at the moment.
The MACD is slightly positive, indicating mild bullish momentum, but the RSI is neutral at 48.756, offering no clear signal. The moving averages are bearish (SMA_200 > SMA_20 > SMA_5), and the stock is trading near its pivot level of 1.126, with resistance at 1.169 and support at 1.084. Overall, the technical indicators suggest a weak trend without a clear buying opportunity.
The company's revenue increased by 21.31% YoY in Q3 2025, which is a positive sign of growth.
Net income dropped significantly by -80.78% YoY, EPS declined by -94.86% YoY, and gross margin fell by -132.89% YoY. Additionally, there are no recent news updates, no significant insider or hedge fund activity, and no recent congress trading data to suggest positive sentiment or interest in the stock.
In Q3 2025, revenue increased to $7,367,000 (up 21.31% YoY), but net income dropped to -$8,503,000 (down -80.78% YoY). EPS fell to -1.59 (down -94.86% YoY), and gross margin dropped to 45.74% (down -132.89% YoY). The financial performance shows growth in revenue but significant declines in profitability and margins.
No data available for analyst ratings or price target changes.
